Financial

News

Grifols rocked by fraud allegation from short seller

Shares in Spanish pharma group Grifols have plummeted after UK-based hedge fund Gotham City Research issued a report claiming it has fraudulently manipulated its financial

News

Gilde’s new investment fund reaches €740m at close

Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi

News

France reported to be probing Sanofi over Dupixent launch

France’s financial prosecutor has reportedly launched an investigation into Sanofi’s “financial communication” surrounding the launch of its biggest-selling drug Dupixent.

News

Moderna swings to loss as COVID sales slump

Shares in Moderna have been under pressure after the company posted a third-quarter loss of $3.6 billion and a steep fall in COVID-19 vaccine sales, although it still thin

News

Novo Nordisk shrugs off supply issues with record sales

Sales of Novo Nordisk’s fast-growing GLP-1 agonist drugs for diabetes and obesity may be held back by supply constraints, but feverish demand is still driving strong growt

News

Sanofi will exit consumer health and boost R&D investment

Sanofi is following in the footsteps of a number of its peers in pharma with a plan to spin off its consumer health business into a separate company and focus its efforts

Grifols rocked by fraud allegation from short seller

Gilde’s new investment fund reaches €740m at close

France reported to be probing Sanofi over Dupixent launch

Moderna swings to loss as COVID sales slump

Novo Nordisk shrugs off supply issues with record sales

Sanofi will exit consumer health and boost R&D investment

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks